CUVL

Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL)

Stock · NASDAQ · Miscellaneous

$6.17as of 8/28/2026

Active signals

Resistance level
$6.81
Industry
Miscellaneous

About CUVL

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's p…

Sector
Miscellaneous
Industry
Miscellaneous

Fundamentals

1-day range
$6.12$6.56
Market cap
$336.61M
P/E (trailing)
14.23
P/E (forward)
EPS (trailing)
$0.64
Dividend yield
0.29%
Beta
0.30
Avg. volume
5.4K
Ex-dividend date
September 8, 2026
Dividend pay date
September 29, 2025
52-week range
$8.35$13.48

Clinuvel Pharmaceuticals Limited American Depositary Shares Competitors

Chosen by industry and closest market cap.

  • CUVL
    Clinuvel Pharmaceuticals Limited American Depositary Shares
    $6.17
    ▼ 8.86%
    Market cap $336.61MP/E 14.23
    $8.35$13.48
  • MVST
    Microvast Holdings Inc. Common Stock
    $0.7227
    ▼ 6.02%
    Market cap $260.60MP/E 5.52
    $0.712$7.12
  • ACTG
    Acacia Research Corporation (Acacia Tech) Common Stock
    $4.48
    ▼ 0.22%
    Market cap $451.07MP/E
    $3.13$5.27
  • ELVA
    Electrovaya Inc. Common Shares
    $6.65
    ▼ 2.85%
    Market cap $459.43MP/E 76.23
    $5.8$17.62
  • SES
    SES AI Corporation Class A Common Stock
    $0.524
    ▼ 4.38%
    Market cap $187.45MP/E
    $0.4909$3.73
  • SLDP
    Solid Power Inc. Class A Common Stock
    $2.34
    ▼ 1.68%
    Market cap $497.61MP/E
    $1.98$8.86
  • CHPT
    ChargePoint Holdings Inc. Common Stock
    $5.57
    ▼ 4.55%
    Market cap $152.28MP/E
    $4.44$12.61

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.